Owing to the presence of a few leading manufacturers of nutraceuticals in Asia Pacific, the competitive
rivalry in the nutraceuticals product market is relatively high, states Transparency Market Research (TMR)
in a new report. To establish a stable position in the Asia Pacific nutraceuticals product market,
manufacturers are focusing on the enhancement of technology and quality of products. Numerous
companies are seeking growth opportunities in highly profitable markets such as India. Countries such as
Australia, Brazil, Japan, and China are also proving to be potential markets for manufacturers to capitalize
on. The key players in the Asia Pacific market for nutraceuticals products are Omvita, APS, Numico,
Celestial Biolabs Ltd., Magnum, Nature’s Answer, Pfizer, and Cadilla Healthcare.
Download Free exclusive Sample of this
report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=165
The market for nutraceuticals in Asia Pacific is expected to expand at a 6.3% CAGR between 2007 and
2017. The market is projected to rise to a value of US$204.8 bn by the end of 2017. On the basis of dietary
supplements, the herbals, vitamins, and mineral segment is likely to emerge dominant in the
nutraceuticals product market in Asia Pacific. Owing to high demand for herbals, vitamins, and mineral
nutraceuticals, the dietary supplement segment is projected to...